Xu, Yongmei
Wang, Haoran https://orcid.org/0000-0003-2781-6264
Wang, Zhangjie
Zhang, Jianxiang
Stancanelli, Eduardo
Xu, Qin
Hou, Yiru
Wang, Chunyu
Zhang, Peng
Gearing, Marla
Liu, Jian https://orcid.org/0000-0001-8552-1400
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | Office of Extramural Research, National Institutes of Health (AG087305)
U.S. Department of Health & Human Services | NIH | Office of Extramural Research, National Institutes of Health (GM142304)
U.S. Department of Health & Human Services | NIH | Office of Extramural Research, National Institutes of Health (AG069039, GM144019, GM148100, MH130476, AG078123, AG088409, and AG066511)
Article History
Received: 16 November 2025
Accepted: 18 May 2026
First Online: 28 May 2026
Competing interests
: Y.X. and J.L. are founders of Glycan Therapeutics and have equity. Z.W. and E.S. are employees of Glycan Therapeutics and have the equity of Glycan Therapeutics. Y.H. was an intern trainee at Glycan Therapeutics and is no longer an employee of Glycan Therapeutics. Other authors declare no competing interests.